NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1932109931 MD
Verify on CMS → David Liljenquist, MD
Endocrinology, Diabetes & Metabolism Physician in Idaho Falls, Idaho.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
23K
Medicare Part D claims · 2K beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
70%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.2K
78 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
David Liljenquist, MD filed 23,200 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Idaho Falls, Idaho, prescribing 70% generic.
- 23K
- Part D claims, 2024
- 70%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥98th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about David Liljenquist, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1932109931), first enumerated 08/01/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 23,200 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.2K in reported industry payments (78 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1932109931 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-HEAVY · BOOK-THIN · PHOTO-ENUM
- NPI-10 1932109931
- ENUM-LEGACY 2005
- TAX-MID 8K Endocrinology, Diabetes
- RX-HEAVY 23K claims
- BOOK-THIN 16 in Idaho
- PHOTO-ENUM Andree De Bustros, M… · 2005
David Liljenquist, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
23,200 ≥ 98th percentile 98% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
David Liljenquist, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Liljenquist, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
23,200 8× vs specialty avg
Specialty distribution in Idaho
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Idaho providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1932109931 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/01/2005 |
Hospital and facility affiliations
Facilities where David Liljenquist, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Rocky Mountain Diabetes And Osteoporosis Center PA
Idaho Falls, ID
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Liljenquist, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
David Liljenquist, MD - brand share 27.0%
Endocrinology, Diabetes & Metabolism Physician average
27% brand-name claims vs 70% generic, on 23,200 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
23,200
Total Claims
$5.0M
Total Drug Cost
1,663
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 51,429.766
- Total Day Supply
- 1,520,504
- Brand vs Generic
- 27% brand / 70% generic
- Brand Drug Cost
- $4.6M
- Generic Drug Cost
- $273K
- Opioid Claims
- 77 (0.3% rate)
- Antibiotic Claims
- 169
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 234, 65-74: 772, 75-84: 548, 85+: 109
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What David Liljenquist, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
1,808 claims
- Metformin Hcl Er
Metformin Hcl Er
1,407 claims
- Atorvastatin Calcium
Atorvastatin Calcium
1,000 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
772 claims
- Ozempic 695
Ozempic
695 claims
- Losartan Potassium 694
Losartan Potassium
694 claims
- Mounjaro 653
Mounjaro
653 claims
- Omeprazole 546
Omeprazole
546 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 1,808 |
| Metformin Hcl Er Metformin Hcl | 1,407 |
| Atorvastatin Calcium | 1,000 |
| Rosuvastatin Calcium | 772 |
| Ozempic Semaglutide | 695 |
| Losartan Potassium | 694 |
| Mounjaro Tirzepatide | 653 |
| Omeprazole | 546 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 524 |
| Pioglitazone Hcl | 481 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in ID →
All providers in Idaho →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How David Liljenquist, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
David Liljenquist, MD's 23,200 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Liljenquist, both outside Idaho so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Idaho
Other clinicians with the same primary specialty enrolled in Idaho, drawn from the same CMS NPPES roster as Liljenquist.
One of 16 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Idaho, 5 are shown here.
Dr. Jason Bell
D.O.
Blackfoot, ID
Dr. Richard Christensen
MD
Boise, ID
Katy Connley
FNP-C
Eagle, ID
Dr. Robert Ennis
MD
Meridian, ID
Dr. Julie Foote
MD
Boise, ID
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is David Liljenquist, MD's specialty? ▼
David Liljenquist, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Idaho Falls, Idaho. Credentials: MD.
How much does David Liljenquist, MD prescribe under Medicare Part D? ▼
In 2024, David Liljenquist, MD wrote 23,200 Medicare Part D claims totaling $5.0M in drug costs for 1,663 beneficiaries.
Where is David Liljenquist, MD located? ▼
David Liljenquist, MD is located at 3910 WASHINGTON PARKWAY, Idaho Falls, ID, 83404. Phone: (208) 523-1122.
What is David Liljenquist, MD's NPI number? ▼
David Liljenquist, MD's National Provider Identifier (NPI) is 1932109931, issued on 08/01/2005.
Does David Liljenquist, MD prescribe more brand-name or generic drugs? ▼
David Liljenquist, MD's prescribing is 27% brand-name and 70% generic drugs by claim count, with $4.6M in brand drug costs.
Does David Liljenquist, MD prescribe opioids? ▼
Yes, David Liljenquist, MD had 77 opioid claims in 2024 with an opioid prescribing rate of 0.3%.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does David Liljenquist, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, David Liljenquist, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl Er, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Liljenquist, MD accept Medicare? ▼
David Liljenquist, MD appears in CMS Medicare data with 23,200 Part D claims and 1,663 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Liljenquist, MD's credentials? ▼
David Liljenquist, MD's NPI is 1932109931 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.